Background In recent years, extracorporeal membrane oxygenation (ECMO) has been
increasingly used in critically ill patients with respiratory or cardiac failure. Heparin is usually …

Objectives Unfractionated heparin (UFH) is the commonly used anticoagulant to prevent
clotting of the ECMO circuit and thrombosis of the cannulated vessels. A side effect of UFH is …

To describe the prevalence of heparin-induced thrombocytopenia (HIT) in patients on
extracorporeal membrane oxygenation (ECMO) and to explore ways to improve the …

Purpose Patients receiving extracorporeal membrane oxygenation (ECMO) are at risk for
thrombocytopenia including heparin-induced thrombocytopenia (HIT). The purpose of this …

Purpose Thrombocytopenia is a frequent and serious adverse event in patients treated with
veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic …

Heparin‐induced thrombocytopenia (HIT) is a life‐threatening prothrombotic, immune‐
mediated complication of unfractionated heparin and low molecular weight heparin therapy …

Background: Heparin-induced thrombocytopenia (HIT) is a serious, immune-mediated
adverse drug reaction to unfractionated heparin (UFH) affecting also patients undergoing …

Background Extracorporeal membrane oxygenation (ECMO) have become more frequently
used in daily ICU practice, heparin-induced thrombocytopenia (HIT) is a rare but life …

Background Heparin-induced thrombocytopenia (HIT) is a severe antibody-mediated
reaction leading to transient prothrombosis. However, its incidence in patients on …

Heparin-induced thrombocytopenia (HIT) is an immune reaction usually secondary to
unfractionated heparin. Anticoagulation management is critical in patients while on …